Skip to main content
. 2020 Jul 11;20:365. doi: 10.1186/s12888-020-02748-0

Fig. 2.

Fig. 2

Patient claims analyzed for BD-related inpatient admissions after ≥10% dose reductions of antipsychotic medication. Outcomes for case and control cohorts were assessed using Kaplan–Meier analysis and compared using a log-rank test. The number of patients at risk is represented for each time point. Case and control cohorts for ≥10%, N = 23,992 each. CI: confidence interval; BD: bipolar disorder